microarray
dna
probe
least
three
role
clinic
virolog
firstli
diagnosi
recognis
caus
agent
ill
secondli
molecular
type
patient
manag
ii
epidemiolog
reason
eg
investig
rout
transmiss
iii
purpos
relat
vaccin
use
thirdli
research
investig
interact
viru
host
cell
microarray
intend
syndrom
diagnost
purpos
requir
genom
specif
probe
captur
unknown
target
viral
sequenc
therebi
reveal
presenc
viru
test
sampl
microarray
intend
type
patient
manag
eg
monitor
antivir
drug
resist
mutat
requir
set
probe
repres
import
sequenc
variant
one
viral
gene
microarray
intend
research
virushost
interact
requir
probe
repres
individu
gene
mrna
either
viru
host
genom
diagnost
microarray
depend
util
versatil
gener
multiplex
random
polymeras
chain
reaction
amplifi
sever
unknown
viral
target
sequenc
patient
sampl
review
exist
potenti
applic
microarray
virolog
problem
need
overcom
futur
success
discuss
dna
array
consist
oligonucleotid
pcr
amplicon
probe
immobilis
solid
surfac
usual
glass
nitrocellulos
nylon
membran
membran
base
array
may
format
line
probe
blot
result
hybridis
bound
probe
label
sequenc
sampl
appli
test
reveal
scan
imag
array
surfac
high
densiti
array
may
thousand
individu
probe
per
cm
refer
microarray
array
prepar
inhous
use
one
sever
array
instrument
avail
commerci
spot
synthet
oligonucleotid
pcr
amplicon
onto
glass
slide
low
high
densiti
microarray
oligonucleotid
also
synthesis
silicon
surfac
photolithograph
combinatori
chemistri
method
similar
use
make
electron
chip
microarray
silicon
surfac
therefor
known
dna
chip
exampl
affymetrix
human
immunodefici
viru
type
antiretrovir
drug
mutat
detect
genechip
compris
set
match
tel
fax
email
address
jonathanclewley
hpaorguk
jp
clewley
mismatch
probe
design
hybridis
proteas
revers
transcriptas
rt
gene
sequenc
detail
technic
inform
array
found
book
schena
natur
genet
review
use
array
review
cum
relman
katomaeda
et
al
manger
relman
see
also
tabl
usual
nomenclatur
array
element
bound
solid
phase
probe
target
solut
contrast
southern
dot
blot
target
bound
probe
solut
case
though
target
dna
rna
sequenc
deriv
test
specimen
process
make
use
array
illustr
fig
check
list
requir
array
project
given
tabl
review
potenti
benefit
microarray
dna
chip
may
abl
offer
clinic
virologist
requir
certain
amount
crystal
ball
gaze
run
risk
overtaken
unforeseen
develop
nevertheless
possibl
paint
broad
pictur
microarray
might
fit
routin
diagnost
laboratori
near
futur
first
nucleic
acid
would
extract
patholog
specimen
mean
autom
instrument
tabl
potenti
use
dna
array
genet
polymorph
viru
detect
presenc
absenc
specif
virus
eg
influenza
viru
li
et
al
rotaviru
confirm
ident
pcr
product
diagnosi
eg
rota
et
al
wang
et
al
epidemiolog
surveil
transmiss
host
rang
determin
monitor
molecular
evolut
new
strain
vaccin
coverag
surveil
antivir
drug
resist
mutat
screen
eg
kozal
et
al
wilson
et
al
vaccin
qualiti
control
eg
polioviru
mump
viru
amexi
et
al
cherkasova
et
al
proudnikov
et
al
detect
presenc
absenc
specif
gene
eg
associ
virul
andor
pathogen
chizhikov
et
al
interact
viru
host
cell
studi
rna
express
profil
viru
follow
infect
includ
drug
effect
vitro
eg
hcmv
chamber
et
al
kshv
jenner
et
al
studi
rna
express
profil
host
follow
infect
includ
drug
effect
vitro
eg
hcmv
zhu
et
al
pvm
domachowsk
et
al
corbeil
et
al
geiss
et
al
use
bacteri
pathogen
fig
illustr
process
involv
make
use
array
top
depict
rout
viru
interest
spot
array
herpesviru
enteroviru
particl
shown
bottom
dna
rna
extract
sampl
amplifi
label
either
green
red
appli
array
bear
immobilis
probe
target
bind
complementari
sequenc
exampl
array
result
shown
right
green
spot
repres
hybridis
probe
target
sequenc
label
red
spot
repres
hybridis
probe
target
sequenc
label
yellow
spot
repres
hybridis
target
sequenc
tabl
requir
viral
dna
array
project
genom
sequenc
data
sever
strain
target
virus
set
pcr
primer
make
amplicon
bound
probe
solid
phase
set
synthet
oligonucleotid
bound
probe
solid
phase
array
instrument
gener
multiplex
pcr
assay
amplifi
fluoresc
label
target
dnarna
hybridis
wash
chamber
scanner
captur
readout
data
array
softwar
interpret
array
readout
data
second
rna
andor
dna
would
subject
enzymat
process
select
amplifi
fluoresc
label
sequenc
genom
viru
present
third
amplifi
nucleic
acid
would
appli
dna
chip
hybrid
complementari
sequenc
probe
repres
known
pathogen
virus
fourth
detect
instrument
softwar
would
interpret
fluoresc
hybridis
signal
chip
provid
readout
identifi
viru
present
origin
specimen
close
realiti
assum
exist
univers
panvir
dna
chip
arguabl
make
littl
diagnost
experiment
sens
patholog
specimen
virus
come
shape
size
clinic
judgement
exercis
assess
probabl
caus
whatev
condit
patient
lead
intellig
guess
virus
test
make
littl
sens
exampl
search
respiratori
virus
gastrointestin
sampl
blood
born
virus
throat
swab
follow
inform
decis
need
also
made
extract
protocol
amplif
primer
use
seem
like
therefor
rather
univers
extract
amplif
method
panvir
dna
specialist
chip
develop
diagnosi
similar
clinic
condit
proto
tabl
exampl
gener
primer
pcr
test
target
refer
papillomavirus
region
coutle
et
al
kleter
et
al
nelson
et
al
enterovirus
ncr
clewley
shih
et
al
zoll
et
al
herpesvirus
dna
polymeras
calvario
et
al
ehler
et
al
minjol
et
al
vandevant
et
al
yamamoto
nakamura
retrovirus
pol
region
burmeist
et
al
pol
region
courgnaud
et
al
gelman
et
al
masciotra
et
al
miura
et
al
yang
et
al
posit
strand
virus
rna
polymeras
chen
plagemann
influenza
virus
np
gene
coira
et
al
rsv
fusion
protein
gene
coira
et
al
hexon
protein
gene
coira
et
al
dengu
virusflavivirus
ncr
protein
gene
chow
et
al
houng
et
al
seah
et
al
arenavirus
ncr
lozano
et
al
rotavirus
segment
type
chip
alreadi
use
mani
laboratori
still
long
way
go
becom
routin
way
instanc
diagnost
elisa
kit
also
probabl
autom
serolog
method
provinc
commerci
supplier
diagnost
viral
dna
chip
accompani
instrument
come
sourc
cost
need
consist
qualiti
control
research
refer
laboratori
howev
involv
much
biotechn
develop
necessari
commerci
suppli
chip
becom
avail
laboratori
also
need
develop
maintain
inhous
method
confirmatori
purpos
detect
obscur
virus
monitor
perform
commerci
equip
develop
array
use
diagnost
purpos
clinic
virolog
laboratori
depend
part
stage
develop
pcr
detect
individu
viral
genom
gener
dna
array
system
need
use
conjunct
nucleic
acid
amplif
method
specif
pcr
method
capabl
amplifi
wide
rang
viral
genom
requir
exampl
investig
wish
develop
microarray
would
use
diagnosi
viral
infect
cn
would
necessari
abl
amplifi
dna
sequenc
rang
herpesvirus
enterovirus
adenovirus
retrovirus
well
jc
influenza
measl
mump
rubella
west
nile
virus
abil
depend
gener
tabl
multiplex
tabl
random
pcr
amplif
procedur
bohland
et
al
elnifro
et
al
wang
et
al
gener
pcr
test
design
one
two
pair
primer
necessari
amplifi
target
sequenc
coira
et
al
daum
et
al
echevarria
et
al
grondahl
et
al
li
et
al
na
et
al
stockton
et
al
xu
et
al
neurolog
ebv
vzv
cmv
adenovirus
enterovirus
bk
jc
calvario
et
al
casa
et
al
fedel
et
al
markoulato
et
al
quereda
et
al
rahau
et
al
read
et
al
robert
et
al
valassina
et
al
blood
born
hcv
hbv
htlvi
ii
heredia
et
al
meng
et
al
vet
et
al
exanthema
measl
rubella
mosquera
mdel
et
al
gastroenter
adenovirus
rotavirus
norwalk
enterovirus
hav
li
et
al
oneil
et
al
std
papillomavirus
gravitt
et
al
zheng
et
al
see
elnifro
et
al
rang
relat
virus
exampl
genu
famili
develop
type
test
region
conserv
amino
acid
nucleotid
sequenc
identifi
target
genom
accomplish
multipl
align
genom
sequenc
mani
strain
viru
possibl
suitabl
conserv
sequenc
found
protein
encod
region
eg
activ
site
enzym
untransl
region
fold
form
selfann
tertiari
structur
eg
ribosom
bind
site
noncod
region
viral
genom
gener
pcr
design
way
conserv
region
dna
polymeras
gene
herpesvirus
ncr
enterovirus
tabl
primer
gener
pcr
often
degener
mix
base
posit
redund
target
sequenc
may
utilis
base
inosin
posit
maximum
degeneraci
eg
see
clewley
et
al
amplif
reagent
thermal
cycl
condit
usual
empir
establish
success
gener
pcr
contrast
gener
pcr
multiplex
pcr
involv
combin
sever
primer
set
target
differ
sequenc
region
one
amplif
reaction
tabl
pcr
neurolog
virus
might
includ
gener
primer
amplifi
herpesviru
enterovirus
togeth
specif
primer
measl
mump
rubella
west
nile
virus
similar
manner
gener
pcr
multiplex
pcr
requir
care
optimis
even
difficult
make
sensit
specif
singl
primer
pair
amplif
reaction
attain
suffici
sensit
may
necessari
split
sampl
sever
aliquot
amplif
select
subset
full
rang
primer
thu
either
one
complex
sever
simpler
multiplex
pcr
contain
mixtur
gener
specif
probe
would
use
amplifi
label
dna
extract
cn
brain
tissu
microarray
would
use
detect
product
multiplex
pcr
neurolog
virus
would
contain
probe
individu
viru
interest
exampl
probe
specif
ebv
vzv
cmv
sequenc
gene
region
gener
primer
would
also
possibl
gener
catchal
probe
uncharacteris
herpesviru
sequenc
recognis
specif
probe
would
miss
similarli
specif
gener
enteroviru
probe
would
includ
array
well
specif
probe
measl
mump
rubella
west
nile
virus
control
probe
array
would
consist
unrel
viral
human
cellular
dna
sequenc
promis
impress
array
date
august
use
diagnost
virolog
describ
derisi
colleagu
howard
hugh
medic
institut
initi
construct
microarray
uniqu
long
oligonucleotid
probe
design
viral
genom
sequenc
includ
entero
rhino
adeno
orthomyxo
paramyxo
nido
retro
hepadna
papillomavirus
seen
list
virus
target
primarili
exclus
respiratori
tract
pathogen
microarray
initi
valid
use
fluoresc
label
kaposi
sarcomaassoci
herp
viru
kshv
respiratori
syncyti
viru
rsv
parainfluenza
polioviru
adenoviru
rhinoviru
rna
prepar
infect
uninfect
cell
cultur
depth
analys
perform
rna
differ
serotyp
rhinovirus
well
rna
extract
nasal
lavag
specimen
patient
common
cold
rna
amplifi
dna
label
use
random
pcr
procedur
bohland
et
al
step
essenti
array
use
success
detect
pathogen
unknown
unrecognis
sequenc
comprehens
version
microarray
use
identif
sar
viru
coronaviru
rota
et
al
microarray
contain
oligonucleotid
repres
complet
viral
genom
sequenc
sar
materi
rna
amplifi
label
random
pcr
approach
hybridis
microarray
dna
hybridis
array
recov
micromanipul
pcramplifi
clone
sequenc
microarray
detect
five
virus
prokaryot
two
eukaryot
consid
pathogen
bioterrorist
might
employ
design
research
lawrenc
livermor
nation
laboratori
usa
wilson
et
al
strategi
employ
multiplex
pcr
amplif
primer
target
multipl
region
genom
pathogen
use
overlap
oligonucleotid
probe
complementari
entir
diagnost
region
microarray
made
way
total
probe
low
densiti
spot
array
recent
describ
specif
detect
enteroviru
shih
et
al
array
design
captur
pcr
amplicon
produc
ncr
gene
enteroviru
genom
develop
diagnost
microarray
confin
human
virolog
use
investig
detect
plant
virus
boonham
et
al
bystricka
et
al
array
also
describ
two
virus
econom
import
shrimp
farmer
white
spot
syndrom
viru
infecti
hypoderm
haematopoiet
necrosi
viru
et
al
latter
worker
use
membran
base
miniarray
system
bound
pcr
amplicon
captur
complementari
strand
label
digoxgenin
hybridis
digoxgenin
label
target
dna
bound
pcr
amplicon
probe
demonstr
colorimetr
array
use
diagnost
purpos
may
consid
least
discriminatori
sens
need
design
abl
pick
member
viru
group
therebi
identifi
novel
pathogen
instanc
shown
identif
sar
agent
coronaviru
rota
et
al
complic
howev
develop
use
type
array
present
exampl
array
use
strain
type
viral
genom
exampl
type
influenza
viru
b
strain
human
group
rotavirus
human
papillomavirus
hpv
hepat
b
c
virus
hbv
hcv
human
immunodefici
viru
type
type
array
exist
format
glass
slide
line
probe
blot
high
densiti
chip
influenza
viru
microarray
base
four
haemagglutinin
ha
three
neuraminidas
na
two
matrix
protein
mp
gene
target
five
differ
influenza
viru
strain
describ
li
et
al
twentyfour
pcr
product
bp
made
gene
target
spot
duplic
onto
glass
slide
togeth
control
e
coli
amplicon
buffer
spot
give
array
thu
gene
repres
two
three
amplicon
three
multiplex
pcr
base
combin
two
four
primer
four
ha
three
na
two
mp
gene
target
use
gener
amplicon
label
fluoresc
dye
test
fluoresc
label
dna
differ
influenza
viru
strain
expect
correct
homolog
hybridis
pattern
observ
array
rotaviru
microarray
base
genotypespecif
oligonucleotid
design
variabl
region
within
conserv
segment
use
classifi
g
genotyp
rotavirus
describ
rotaviru
identifi
averag
nine
differ
specif
probe
clinic
relev
genotyp
spot
glass
via
aminolink
order
way
pcr
primer
region
common
group
rotavirus
use
make
amplicon
fluoresc
label
one
primer
biotinyl
allow
separ
two
amplicon
dna
strand
streptavidin
bind
way
test
sequenc
could
appli
array
fluoresc
label
singl
strand
dna
test
rotaviru
isol
expect
correl
genotyp
result
determin
sequenc
seen
influenza
viru
array
detail
routin
use
rotaviru
array
diagnost
laboratori
environ
yet
publish
immedi
precursor
dna
array
suitabl
use
type
viral
genom
revers
hybridis
line
probe
blot
develop
hla
genotyp
scientist
cetu
corpor
pcr
invent
bugawan
et
al
saiki
et
al
subsequ
first
viral
applic
type
hcv
develop
innogenet
stuyver
et
al
stuyver
et
al
besid
hcv
line
probeblot
assay
describ
detect
mutat
revers
transcriptas
gene
stuyver
et
al
genotyp
detect
lamivudineresist
hbv
aberl
et
al
swenson
et
al
type
hpv
gravitt
et
al
kleter
et
al
levi
et
al
van
doorn
et
al
although
detail
may
vari
gener
line
probe
blot
strip
made
immobil
captur
ie
probe
oligonucleotid
onto
nitrocellulos
nylon
membran
oligonucleotid
identifi
multipl
sequenc
align
target
viral
gene
synthesi
oligonucleotid
probe
tail
dt
residu
enzymat
conjug
bsa
bound
membran
dt
tail
bsa
act
spacer
solid
phase
base
oligonucleotid
probe
complementari
target
viral
sequenc
target
prepar
pcr
specif
product
amplifi
biotin
residu
incorpor
end
use
biotinyl
primer
denatur
singl
strand
dna
treatment
alkali
hybridis
probe
biotinyl
dna
strand
reveal
streptavidinalkalin
phosphatas
colorimetr
detect
step
two
descript
line
probeblot
assay
hpv
provid
good
exampl
technolog
may
use
one
known
line
blot
assay
lba
make
use
bp
amplicon
region
hpv
use
primer
set
call
pgmi
gravitt
et
al
gravitt
et
al
primer
set
mixtur
pool
upstream
downstream
oligonucleotid
assay
known
line
probe
assay
lipa
use
primer
call
spf
amplifi
small
bp
amplicon
within
region
kleter
et
al
kleter
et
al
spf
primer
mixtur
like
pgmi
primer
consensu
primer
base
highli
conserv
sequenc
primer
set
detect
similar
number
hpv
anogenit
genotyp
comparison
two
method
carri
panel
cervic
scrape
although
minor
differ
detect
hpv
type
seen
overal
found
match
equal
suitabl
diagnost
use
van
doorn
et
al
either
two
assay
could
readili
adapt
microarray
format
oligonucleotid
would
use
appli
glass
slide
rather
membran
pcr
product
would
label
fluoresc
dye
eg
hybridis
would
use
slide
hybridis
chamber
array
scanner
softwar
would
use
obtain
result
instead
colorimetr
visualis
two
avail
hpv
line
probe
assay
thu
shown
equal
use
though
publish
evalu
line
probe
assay
method
pcr
product
characteris
gold
standard
method
must
compar
sequenc
amplicon
one
evalu
line
probe
assay
compar
sequenc
detect
drug
resist
mutat
revers
transcriptas
gene
conclud
specimen
line
probe
assay
insuffici
reliabl
use
puchhammerstockl
et
al
one
five
sampl
gave
result
could
interpret
antivir
drug
genotyp
determin
sequenc
howev
anoth
studi
found
although
discrep
result
obtain
line
probe
assay
suitabl
use
clinic
virolog
laboratori
antiretrovir
drug
mutat
detect
altern
sequenc
wilson
et
al
latter
evalu
also
found
affymetrix
genechip
detect
mutat
proteas
revers
transcriptas
gene
satisfactori
method
affymetrix
genechip
first
commerci
microarray
offer
use
clinic
virolog
initi
develop
genotyp
proteas
gene
later
also
revers
transcriptas
gene
kozal
et
al
evalu
perform
compar
dna
sequenc
done
sever
laboratori
gener
found
genotyp
chip
highli
concord
sequenc
gunthard
et
al
hanna
et
al
wilson
et
al
young
et
al
affymetrix
proteas
genechip
consist
high
densiti
array
oligonucleotid
made
lightdirect
combinatori
chemic
synthesi
glass
surfac
lipshutz
et
al
array
overlap
oligonucleotid
design
abl
interrog
posit
subtyp
b
proteas
gene
mean
set
four
oligonucleotid
differ
one
base
posit
nucleotid
proteas
gene
target
prepar
rna
revers
transcriptas
pcr
primer
bear
rna
polymeras
promot
amplicon
produc
pcr
way
promot
sequenc
end
could
transcrib
rna
rna
polymeras
presenc
fluoresceinlabel
rutp
fragment
rna
hybridis
dna
chip
pattern
hybridis
could
read
sequenc
proteas
gene
power
method
illustr
two
challeng
aris
use
oligonucleotid
microarray
fulli
characteris
viral
gene
firstli
design
synthesi
full
overlap
set
redund
oligonucleotid
technic
difficult
beyond
resourc
mani
clinic
virolog
laboratori
secondli
sequenc
oligonucleotid
use
chip
must
base
singl
known
sequenc
case
subtyp
b
mean
separ
chip
would
need
made
subtyp
exampl
subtyp
c
compris
half
worldwid
infect
today
rapidli
extens
target
genom
mutat
difficult
design
sequenc
specif
oligonucleotid
chip
abl
catch
genom
variant
might
present
individu
quasispeci
alreadi
preval
commun
obvious
problem
fast
chang
genom
target
like
slowli
evolv
one
like
hpv
microarray
perhap
form
gener
oligonucleotid
microchip
potenti
use
examin
batch
vaccin
ensur
free
viral
genom
sequenc
amexi
et
al
cherkasova
et
al
petricoin
et
al
proudnikov
et
al
one
initi
hope
oligonucleotid
microarray
could
use
dna
sequenc
hybridis
southern
although
realis
larg
scale
small
pcr
amplicon
bp
characteris
array
possibl
oligonucleotid
total
probe
use
array
type
describ
detect
quantif
neurovirul
mutant
oral
polioviru
vaccin
proudnikov
et
al
short
sequenc
region
less
bp
amplifi
end
polioviru
genom
vaccin
prepar
label
texa
red
fluoresc
dye
appli
microarray
contain
chemic
immobilis
oligonucleotid
pattern
spot
observ
follow
hybridis
wash
characterist
sequenc
appli
practic
meant
revert
vaccin
prepar
could
recognis
studi
use
microarray
bear
base
long
oligonucleotid
need
determin
whether
approach
applic
longer
pcr
product
altern
use
microarray
gener
oligonucleotid
characteris
viru
stock
use
array
strain
specif
oligonucleotid
approach
also
investig
analysi
vaccinederiv
poliovirus
well
analysi
jeryl
lynn
strain
mump
viru
amexi
et
al
cherkasova
et
al
microarray
use
two
way
virolog
firstli
studi
rna
express
profil
viru
follow
infect
includ
drug
effect
vitro
chamber
et
al
jenner
et
al
secondli
studi
rna
express
profil
host
follow
infect
includ
drug
effect
vitro
corbeil
et
al
domachowsk
et
al
geiss
et
al
iizuka
et
al
zhu
et
al
applic
two
complementari
approach
microbiolog
review
cum
relman
katomaeda
et
al
manger
relman
rna
express
hcmv
cell
cultur
presenc
absenc
cycloheximid
ganciclovir
analys
array
oligonucleotid
repres
hcmv
orf
made
glass
slide
chamber
et
al
similarli
array
amplicon
repres
orf
made
nylon
membran
use
compar
express
viral
mrna
latenc
tpainduc
lytic
replic
jenner
et
al
group
studi
poxviru
express
way
laassril
et
al
evan
person
commun
gene
express
investig
help
microarray
probe
oligonucleotid
cdna
repres
mrnasi
express
genesof
host
cell
schena
et
al
type
host
cell
gene
array
conveni
obtain
commerci
eg
affymetrix
studi
hcmv
infect
role
cellular
gene
onset
viral
dna
replic
analys
hybridis
label
mrna
infect
cell
affymetrix
gene
chip
contain
human
gene
probe
zhu
et
al
level
mrna
found
chang
factor
similarli
express
mous
cellular
mrna
infect
paramyxoviru
pneumonia
viru
mice
analys
use
affymetrix
mous
gene
microarray
chip
domachowsk
et
al
gene
express
compar
hepatocellular
carcinoma
induc
either
hbv
hcv
iizuka
et
al
messeng
rna
infect
tcell
hybridis
cellular
cdna
identifi
gene
involv
tcell
signal
subcellular
traffick
transcript
regul
geiss
et
al
manner
effect
infect
tcell
transcript
examin
use
affymetrix
gene
chip
regul
differenti
express
cellular
gene
observ
corbeil
et
al
suggest
hybridis
label
target
dna
deriv
patient
infect
pathogen
could
use
diagnost
cum
relman
author
wrote
uniqu
constel
virul
factor
express
specif
pathogen
elicit
uniqu
transcript
respons
host
uniqu
transcript
pattern
could
captur
readout
array
could
use
diagnost
signatur
simplist
might
done
hybridis
label
cdnamrna
pbmc
patient
array
sequenc
repres
human
gene
give
array
profil
diagnost
specif
pathogen
particular
advantag
approach
success
would
one
sampl
would
need
sever
pathogen
would
allow
detect
earli
late
infect
uncultiv
pathogen
addit
might
possibl
infer
time
sinc
exposur
pathogen
transcript
pattern
tempor
characterist
cum
relman
asid
cost
difficulti
associ
design
make
suitabl
array
obviou
problem
use
one
qualiti
control
difficulti
standardis
reproduc
associ
larg
number
probe
array
larg
number
slide
need
made
although
possibl
rehybrid
array
unlik
accept
diagnost
use
increas
nois
loss
signal
come
reus
also
difficult
relat
signal
array
back
amount
viru
genom
present
origin
specimen
make
quantif
problem
array
oligonucleotid
pcr
amplicon
spot
glass
slide
made
inhous
may
contamin
pcr
amplicon
use
larg
amount
product
made
may
also
problem
hybridis
reaction
exampl
sequenc
hybridis
togeth
obviou
reason
probe
target
selfann
intern
complementari
region
sequenc
commerci
bought
array
may
inflex
base
one
target
sequenc
eg
affymetrix
genechip
subtyp
b
proteas
mutat
kozal
et
al
forego
discuss
seen
microarray
gain
foothold
virolog
prospect
serv
use
diagnost
tool
similar
technolog
less
readi
abl
fulfil
diagnost
role
includ
protein
array
biosensor
protein
array
prepar
antigen
antibodi
bound
solid
phase
analog
oligonucleotid
amplicon
probe
use
captur
specif
antibodi
antigen
de
wildt
et
al
emili
cagney
holt
et
al
walter
et
al
essenti
immunoassay
microarray
format
schweitzer
kingsmor
protein
array
describ
torch
screen
wherebi
toxoplasma
gondii
rubella
viru
cmv
antigen
print
glass
slide
slide
first
incub
serum
sampl
subsequ
fluoresc
label
secondari
antibodi
human
igg
igm
bound
print
antigen
detect
confoc
scan
microscopi
good
concord
obtain
microarray
result
elisa
mezzasoma
et
al
microarray
oligosaccharid
nitrocellulos
develop
captur
carbohydraterecogn
protein
might
possibl
develop
viral
diagnosi
fukui
et
al
biosensor
defin
small
devic
util
biolog
reaction
detect
target
analyt
wang
two
way
either
bioaffin
biocatalysi
bioaffin
array
involv
target
analyt
bind
ligand
immobilis
solid
phase
eg
oligonucleotid
instead
necess
detect
hybridis
probe
target
colorimetr
radioact
mean
hybridis
detect
electron
mean
achiev
via
transduc
point
probe
attach
solid
phase
class
biosensor
also
includ
hybridis
biosensor
reli
conform
chang
induc
hybridis
exampl
molecular
beacon
bear
quencher
fluorophor
dye
biocatalyt
array
involv
immobilis
enzym
use
recognis
substrat
enzym
case
target
array
signal
gener
enzym
catalys
specif
reaction
presenc
target
analyt
appli
array
reaction
may
recognis
either
colorimetr
alli
via
electron
transduc
surfac
array
microarray
use
clinic
virolog
laboratori
develop
public
commerci
sector
public
laboratori
probabl
fit
research
interest
laboratori
develop
may
easili
transfer
laboratori
like
commerci
supplier
deliv
qualiti
control
viral
diagnost
array
line
probe
assay
made
avail
present
whether
perform
match
probabl
high
cost
remain
seen
fast
easi
autom
supplant
present
rang
genom
serolog
diagnost
test
must
also
abl
match
term
sensit
specif
may
prove
stiffer
challeng
